The following commentary comes from an independent investor or market observer as part of TheStreet's guest contributor program, which is separate from the company's news coverage. The opinions expressed are those of the author and do not represent the views of TheStreet or its management.NEW YORK (
Hewlett-Packard: Another software industry staple Hewlett-Packard ( HPQ) should also be avoided, having dropped -12% since April. And unlike other lagging blue chips that at least pay back shareholders, a dividend yield of less than 1% isn't comforting anyone either. Intel: Since reaching a peak in April, Intel ( INTC) has dropped -11%, compared to large gains by the broader markets. The tech giant looked like it might turn it around, but the stock has gained just +1% in the last three months. Johnson & Johnson: Losses of -3% in 12 months and -6% since November make Johnson & Johnson ( JNJ) a stock to sell at the moment. Down earnings numbers aren't helping JNJ's cause either. As drug patent expiration and generic competition reshapes the drug marketplace, JNJ is risking being left behind. Merck & Co: Global health care company Merck & Co. ( MRK) is down -11% in the last year. A stock loss of -9% year-to-date and a net profit margin of -4% only add to MRK's woes.
Related Article: Microsoft: Software giant Microsoft ( MSFT) may have posted a small gain in the last three months, but Bill Gates' company is down -4% over 12 months and -5% since mid January. The tech giant may have a virtual monopoly on office software, but it lacks the growth and consumer appeal of companies like Apple ( AAPL) that are connecting with both gadget geeks and 21st century businesses. 12 Best and Worst Energy Stocks Related Article: Procter & Gamble: Packaged goods and personal products behemoth Procter & Gamble ( PG) was showing strong growth until mid-January, and the stock is now down -4% in that time. Quarterly earnings growth of -29%, year-over-year is also troubling, and a sign of rough times ahead for stockholders. >To see these stocks in action, visit the 11 Blue-Chips to Sell portfolio on Stockpickr. As of this writing, Louis Navellier did not own a position in any of the stocks named here. 5 Flashy New Toys from Apple for 2012